"Measures for Supervision and Inspection of Drug Clinical Trial Institutions (Trial)" Publicity Meeting Held
release time:2023-12-12
On November 29, the State Food and Drug Administration held a publicity meeting on the measures for the Supervision and Inspection of Drug Clinical trial institutions (for trial implementation) (hereinafter referred to as the "measures") in Xi'an. Huang Guo, member of the leading party group and deputy director of the State Food and Drug Administration, attended the publicity meeting and delivered a speech.
The meeting said that the State Food and Drug Administration attaches great importance to the supervision of clinical trials, takes various measures to promote the quality and efficiency of clinical trials, and continuously strengthens the quality supervision of clinical trials. It is necessary to deeply understand the great significance of the high-quality development of clinical trials for people's health and the innovation of the pharmaceutical industry, do a good job in the implementation of the Measures, continue to increase the supervision of clinical trials, strengthen the construction of the team of inspectors, strengthen departmental linkage and social co-governance, and vigorously Carry out scientific research on drug supervision, create a good R & D ecology that strictly adheres to the bottom line and develops in compliance, and makes greater contributions to the high-quality of the industry.
At the meeting, relevant responsible persons of Beijing, Shanghai, Jiangxi, Shandong, Guangdong and Shaanxi (municipal) bureaus exchanged experiences.
Related News
Contact Information
Contact Phone
Address: Building 3, No. 1, Kaiyuan Road, Yong'an Industrial Cluster Zone, Fuying Street, Xianju County, Taizhou City, Zhejiang Province